Corrigendum to ‘Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study’ [Respir Investig 64/5 (2026) 101503]

Respiratory Investigation · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles